HST
53
4
PWR
63
3
MA
60
5
MDLZ
28
2
KR
50
5
GM
55
6
CAT
47
3
IBM
53
2
DLTR
52
8
DG
14
6
ROST
60
3
WAT
55
11
GS
65
16
EBAY
42
2
LB
16
9
DOV
48
2
AON
25
4
CHD
34
7
O
26
16
RF
44
10
HST
53
4
PWR
63
3
MA
60
5
MDLZ
28
2
KR
50
5
GM
55
6
CAT
47
3
IBM
53
2
DLTR
52
8
DG
14
6
ROST
60
3
WAT
55
11
GS
65
16
EBAY
42
2
LB
16
9
DOV
48
2
AON
25
4
CHD
34
7
O
26
16
RF
44
10
Financhill
Back

BridgeBio Pharma Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

BBIO
BridgeBio Pharma

Last Price:
$26.49
Seasonality Move:
-20.12%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

BridgeBio Pharma Price Quote

$26.49
-0.01 (1.07%)
(Updated: December 21, 2024 at 5:16 AM ET)

BridgeBio Pharma Key Stats

Sell
39
BridgeBio Pharma (BBIO) is a Sell
Day range:
$26.02 - $26.90
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.18
P/B ratio:
0%
Volume:
4M
Avg. volume:
2.5M
1-year change:
-30.64%
Market cap:
$5B
Revenue:
$9.3M
EPS:
$-2.41

How Much Does BridgeBio Pharma Make?

Data Unavailable

Is BridgeBio Pharma Growing As A Company?

Data Unavailable

BridgeBio Pharma Stock Price Performance

  • Did BridgeBio Pharma Stock Go Up Last Month?
    BridgeBio Pharma share price went up by 15% last month
  • Did BBIO's Share Price Rise Over The Last Year?
    BBIO share price fell by -30.64% over the past 1 year

What Is BridgeBio Pharma 52-Week High & Low?

BridgeBio Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BridgeBio Pharma?

Data Unavailable

Is BridgeBio Pharma Cash Flow Positive?

Data Unavailable

BridgeBio Pharma Return On Invested Capital

Data Unavailable

BridgeBio Pharma Earnings Date & Stock Price

BridgeBio Pharma Competitors

  • Who Are BridgeBio Pharma's Competitors?
    Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Cassava Sciences Inc (SAVA)
    • Vertex Pharmaceuticals Inc (VRTX)

BridgeBio Pharma Dividend Yield

Data Unavailable

BridgeBio Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.14%
Revenue: -33.22% -19.2%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 48.56
Upside from Last Price: 83.28%

Major Shareholders

Data Unavailable